Serum lipids and glucose tolerance in diabetes during therapy with a thyromimetic agent.
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005989:Glycerides / Q000378:metabolism*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007455:Iodine / Q000378:metabolism*; D008297:Male; D010648:Phenylacetates / Q000627:therapeutic use*; D011485:Protein Binding / Q000187:drug effects; D014280:Triglycerides / Q000378:metabolism
D000924:Anticholesteremic Agents; D001786:Blood Glucose; D005989:Glycerides; D010648:Phenylacetates; D014280:Triglycerides; D007455:Iodine; D002784:Cholesterol